Controlling CRISPR Through Law: Legal Regimes as Precautionary Principles
Sherkow, Jacob S.
Loading…
Permalink
https://hdl.handle.net/2142/110349
Description
Title
Controlling CRISPR Through Law: Legal Regimes as Precautionary Principles
Author(s)
Sherkow, Jacob S.
Issue Date
2019-10-09
Keyword(s)
crispr
precautionary
bioethics
governance
law
Abstract
Since its advent in 2012, CRISPR has spawned a cottage industry of bioethics literature. One principal criticism of the technology is its virtually instant widespread adoption prior to deliberative bodies conducting a meaningful ethical review of its harms and benefits—a violation, to some, of bioethics' “precautionary principle.” This view poorly considers, however, the role that the law can play—and does, in fact, play—in policing the introduction of ethically problematic uses of the technology. This Perspective recounts these legal regimes, including regulatory agencies and premarket approval, tort law and deterrence, patents and ethical licenses, funding agencies and review boards, as well as local politics. Identifying these legal regimes and connecting them to the precautionary principle should be instructive for bioethicists and policy makers who wish to conduct ethical reviews of new applications of CRISPR prior to their introduction.
This is the default collection for all research and scholarship developed by faculty, staff, or students at the University of Illinois at Urbana-Champaign
Use this login method if you
don't
have an
@illinois.edu
email address.
(Oops, I do have one)
IDEALS migrated to a new platform on June 23, 2022. If you created
your account prior to this date, you will have to reset your password
using the forgot-password link below.
